Search
Bill number does not exist. Enter a vaild keyword.

Legislation

Original
Chamber
1st
Reading
Referral
to Cmte
2nd
Reading
3rd
Reading
Opposite
Chamber
1st
Reading
Referral
to Cmte
2nd
Reading
3rd
Reading
Review in
Original Chamber
Passed Both
Chambers
Conf. Cmte
(if necessary)
To Governor
Title
Public Health - Expensive Drugs - Manufacturer Reporting and Drug Price Transparency Advisory Committee
Sponsored by
Delegates Bromwell, Anderson, Atterbeary, Barkley, B. Barnes, D. Barnes, Barve, Beidle, Branch, Brooks, Carr, Chang, Clippinger, Conaway, Cullison, Davis, Dumais, Ebersole, Fennell, Fraser-Hidalgo, Frick, Frush, Gaines, Glenn, Gutierrez, Haynes, Healey, Hettleman, Hill, Hixson, Holmes, C. Howard, Jackson, Jameson, Jones, Kaiser, Kelly, Knotts, Korman, Krimm, Lafferty, Lam, Lierman, Lisanti, Luedtke, McCray, McIntosh, A. Miller, Moon, Morales, Oaks, Patterson, Pena-Melnyk, Platt, Proctor, Robinson, Rosenberg, Sample-Hughes, Sanchez, Sophocleus, Stein, Sydnor, Tarlau, Turner, Valderrama, Vallario, Waldstreicher, Walker, A. Washington, M. Washington, C. Wilson, K. Young, P. Young, and R. Lewis
Status
In the House - Hearing 2/23 at 1:00 p.m.
Analysis
Fiscal and Policy Note
Synopsis
Requiring, on or before March 31 each year, the manufacturer of an expensive drug sold or offered for sale in the State to file with the Secretary of Health and Mental Hygiene a specified annual report; establishing the Drug Price Transparency Advisory Committee; requiring a manufacturer of an expensive drug to file a notice with the Secretary before increasing a specified price or a specified cost by more than a specified percentage or amount during specified periods of time; etc.
Committees
Details
Cross-filed with: SB0437
Bill File Type: Regular
Effective Date(s): October 1, 2017
History
Legislation History
Chamber
House
Calendar Date
2/01/2017
Legislative Date
2/01/2017
Action
First Reading Health and Government Operations
Proceedings
Chamber
House
Calendar Date
2/08/2017
Legislative Date
2/08/2017
Action
Hearing 2/23 at 1:00 p.m.
Proceedings
Chamber Calendar Date Legislative Date Action Proceedings
House 2/01/2017 2/01/2017 First Reading Health and Government Operations
Text - First - Public Health - Expensive Drugs - Manufacturer Reporting and Drug Price Transparency Advisory Committee
House 2/08/2017 2/08/2017 Hearing 2/23 at 1:00 p.m.
File Code
Subjects
Statutes
(   21-228, 21-229, 21-229.1 )
Last Updated: 2/3/2020 2:30 PM